Anti-PHLD/ GPLD1/ GPIPLD functional antibody

Anti-PHLD/ GPLD1/ GPIPLD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GPLD1/GPLD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0954-Ab-1/ GM-Tg-hg-SE0954-Ab-2Anti-Human GPLD1 monoclonal antibodyHuman
GM-Tg-rg-SE0954-Ab-1/ GM-Tg-rg-SE0954-Ab-2Anti-Rat GPLD1 monoclonal antibodyRat
GM-Tg-mg-SE0954-Ab-1/ GM-Tg-mg-SE0954-Ab-2Anti-Mouse GPLD1 monoclonal antibodyMouse
GM-Tg-cynog-SE0954-Ab-1/ GM-Tg-cynog-SE0954-Ab-2Anti-Cynomolgus/ Rhesus macaque GPLD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0954-Ab-1/ GM-Tg-felg-SE0954-Ab-2Anti-Feline GPLD1 monoclonal antibodyFeline
GM-Tg-cang-SE0954-Ab-1/ GM-Tg-cang-SE0954-Ab-2Anti-Canine GPLD1 monoclonal antibodyCanine
GM-Tg-bovg-SE0954-Ab-1/ GM-Tg-bovg-SE0954-Ab-2Anti-Bovine GPLD1 monoclonal antibodyBovine
GM-Tg-equg-SE0954-Ab-1/ GM-Tg-equg-SE0954-Ab-2Anti-Equine GPLD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0954-Ab-1/ GM-Tg-hg-SE0954-Ab-2; GM-Tg-rg-SE0954-Ab-1/ GM-Tg-rg-SE0954-Ab-2;
GM-Tg-mg-SE0954-Ab-1/ GM-Tg-mg-SE0954-Ab-2; GM-Tg-cynog-SE0954-Ab-1/ GM-Tg-cynog-SE0954-Ab-2;
GM-Tg-felg-SE0954-Ab-1/ GM-Tg-felg-SE0954-Ab-2; GM-Tg-cang-SE0954-Ab-1/ GM-Tg-cang-SE0954-Ab-2;
GM-Tg-bovg-SE0954-Ab-1/ GM-Tg-bovg-SE0954-Ab-2; GM-Tg-equg-SE0954-Ab-1/ GM-Tg-equg-SE0954-Ab-2
Products NameAnti-GPLD1 monoclonal antibody
Formatmab
Target NameGPLD1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPLD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0954-Ag-1Recombinant multi-species PHLD/ GPLD1/ GPIPLD protein


    Target information

    Target IDGM-SE0954
    Target NameGPLD1
    Gene ID2822,14756,291132,707782,478735,101088486,287025,100067517
    Gene Symbol and Synonyms6330541J12Rik,GPIPLD,GPIPLDM,GPLD1,PIGPLD,PIGPLD1,PLD
    Uniprot AccessionP80108,Q8R2H5,P80109
    Uniprot Entry NamePHLD_HUMAN,PHLD_RAT,PHLD_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112293
    Target ClassificationN/A

    The target: GPLD1, gene name: GPLD1, also named as GPIPLD, GPIPLDM, PIGPLD, PIGPLD1, PLD. Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.